SMARCB1 and central nervous system cancer: Altogether, these findings indicate that the overexpression of MEG3 can inhibit glioma cell progression, while the overexpression of miR-6088 or the inhibition of SMARCB1 can partially reverse the inhibitive effect of pcDNA3.1-MEG3 on glioma cells.